First-phase insulin release is beginning to get the recognition it deserves. But we still have a long way to go to understand it.
“It’s a bit esoteric,” Dr. Alain Baron, Amylin Pharmaceuticals’ senior vice president of research, told me Friday. “Most physicians don’t understand its significance.”
A pill form of GLP-1 may be coming. That’s the gist of a late breaking abstract at the American Diabetes Association’s annual convention that concluded at noon today. The embargo on this abstract expired a few minutes ago.
Whenever I offer a cup of coffee to a friend of mine, he always replies, “I don’t do drugs.”
He’s right that coffee is a drug, but even he does drugs. Everybody does some drugs.
Vitamin D keeps getting more and more respect. While planning to write here about it for those of us with diabetes, I gathered reports for the past year about its value in treating many conditions.
You can find information about the medicines you take all over the Internet. Hype and scams surround us. So, what information can you trust?
We don’t know yet if not getting enough sleep causes high blood glucose or if high blood glucose causes us not to get enough sleep. But a new study shows for the first time that too little or poor sleep does go along with higher A1C levels.